Experience

Aaron Nudelman

    • argenx – $557 Million Follow-On Offering 


    • Novo Holdings Leads $72 Million Series E for LanzaTech 


    • Advaxis – $30 Million Registered Direct Offering 


    • Gemphire Therapeutics – $30 Million IPO 


    • Oncobiologics – $40 Million IPO and Private Placement 


    • Syndax – $58 Million IPO 


    • Strongbridge Biopharma IPO 


    • ProNAi – $158 Million IPO 


    • Eleven Biotherapeutics IPO 


    • TetraLogic Initial Public Offering